Three Scientific Posters for You
15th Annual WRIB Meeting Recap on Immunogenicity
Have a look at these three scientific posters that were presented by our scientific experts at the 15th WRIB (Workshops on Recent Issues in Bioanalysis):
Dual Purpose of a Cell-Based Assay for an Agonist of the GLP-2 Receptor
During drug development, cell-based assays are used for multiple purposes. These include early proof of concept to identify a drug product’s pharmacological activity, and further studies to determine whether neutralizing anti-drug antibodies (NAbs) are present.
Development of an Oligonucleotide Drug Immunogenicity Assay: a Case for the Characterization of the Immune Response
While the immunogenicity of protein-based biologics and the characteristics of the antibody responses directed against them are well understood, the same is not true for other categories of biologics.
Using Anti-Drug-Antibody Screening Assay to Resolve Selectivity Issues in Toxicokinetic Ligand-Binding Assay
Selectivity evaluation for regulatory toxicokinetic (TK) quantitative ligand binding assays (LBAs) is required to meet accuracy requirements for at least 80% of the individual selectivity matrix lots.
Through different techniques, our experts will help you determine the best possible approach for your molecule, and select the optimal platform to produce high-quality results. Book a consult with one of our experts to discuss how we can support your program.
You may also be interested in the following:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.